Trial intelligence / Profile preview

DLBS1033 in Acute Ischemic Stroke

NCT04425590Phase 3Unknown

Sponsor
Duta Wacana Christian University
Start
Apr 2020
Primary completion
Aug 2020
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 3 trial of DLBS1033 in ischemic stroke, sponsored by Duta Wacana Christian University. Status: unknown.

02

Drugs

DLBS1033
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT04425590.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04425590.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call